Saeed Mohammad
Pediatric Transplant Hepatology · Nashville, TNNPI 1942357736
Payments from drug & device makers
Across 351 payments — averaging $1777.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mirum Pharmaceuticals, Inc.$260K
- Ipsen Biopharmaceuticals, Inc$131K
- Albireo Pharma, Inc.$121K
- Gilead$88K
- Travere Therapeutics, Inc.$14K
- AstraZeneca$7K
- plus $4K from 2 others
What the payments were for
- Consulting fees$151,42742%
- Speaking & faculty fees$149,71942%
- Travel & lodging$48,54314%
- Food & beverage$7,0562%
- Entertainment$960%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mirum Pharmaceuticals, Inc. | 168 | $259,760 |
| Ipsen Biopharmaceuticals, Inc | 70 | $131,433 |
| Albireo Pharma, Inc. | 74 | $120,540 |
| Gilead | 18 | $88,050 |
| Travere Therapeutics, Inc. | 7 | $13,578 |
| AstraZeneca | 12 | $6,674 |
| Echosens North America, Inc. | 1 | $3,600 |
| Bracco Diagnostics Inc. | 1 | $159 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few pediatric transplant hepatology providers in Tennesseeto place this figure against a meaningful peer group, so we don't.
Other pediatric transplant hepatology in Nashville
- Anita PaiNashville$96
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.